sequenti high-dos methotrex fluorouracil doxorubicin step treatment advanc gastric cancer trial european organ research treatment cancer gastrointestin tract cooper group prospect phase iii multicent trial patient advanc measur nonmeasur gastric cancer methotrex mtx fluorouracil adriamycin doxorubicin farmitalia carlo erba milan itali famtx adriamycin mitomycin fam result superior respons rate surviv median week week famtx cumul thrombocytopenia fam famtx famtx protocol refer treatment futur clinic trial therapeut outcom advanc gastric cancer 